Cistus Incanus

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Cistus Incanus is a natural product and sold as a nutritional supplement. It works against the retrovirus HIV by targetting the proteins.[1] It works as an entry inhibitor[1] at the entry level which means it prevents the entry of the virus into the cell in a very early state and prevents virus particles from docking on cells.

It works also against bacteria[2] and viruses[3] and has anti-fungal activity.[4]

It may have a positive effect against the cause of ME.[5]

Learn more[edit | edit source]

It is used in the treatment regime against ME of Ms Voss to prevent the use of Raltegravir.

References[edit | edit source]

  1. 1.0 1.1 Rebensburg, Stephanie; Helfer, Markus; Schneider, Martha; Koppensteiner, Herwig; Eberle, Josef; Schindler, Michael; Gürtler, Lutz; Brack-Werner, Ruth (February 2, 2016). "Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins". Scientific Reports. 6 (1): 20394. doi:10.1038/srep20394. ISSN 2045-2322.
  2. Demetzos, Costas; Loukis, Argyris; Spiliotis, Vasilis; Zoakis, Nikolaos; Stratigakis, Nikolaos; Katerinopoulos, Haralambos E. (July 1, 1995). "Composition and Antimicrobial Activity of the Essential oil of Cistus creticus L." Journal of Essential Oil Research. 7 (4): 407–410. doi:10.1080/10412905.1995.9698549. ISSN 1041-2905.
  3. Ehrhardt, Christina; Hrincius, Eike R.; Korte, Virginia; Mazur, Igor; Droebner, Karoline; Poetter, Anne; Dreschers, Stephan; Schmolke, Mirko; Planz, Oliver; Ludwig, Stephan (October 2007). "A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance". Antiviral Research. 76 (1): 38–47. doi:10.1016/j.antiviral.2007.05.002. ISSN 0166-3542. PMID 17572513.
  4. Bouamama, H.; Villard, J.; Benharref, A.; Jana, M. (November 1, 1999). "Antibacterial and antifungal activities of Cistus incanus and C. monspeliensis leaf extracts". Therapie. 54 (6): 731–733. ISSN 1958-5578. PMID 10709448.
  5. Https:// (June 9, 2018). "ME versus CFS: #Arztanfragen - Mein Therapieregime für die antiretrovirale Behandlung bei Myalgischer Enzephalomyelitis". ME versus CFS. Retrieved March 2, 2023.